GSK’s Valtrex Clears FDA Cmte.; Herpes Transmission Endpoints Debated
Executive Summary
Clinical studies for genital herpes drugs intended to demonstrate a reduction in disease transmission should include seroconversion as a primary endpoint, FDA's Antiviral Drugs Advisory Committee agreed May 14
You may also be interested in...
Valtrex Safe-Sex Brochure In Development After Approval For Transmission
GlaxoSmithKline is creating a patient education brochure to be available in October that will emphasize safe-sex practices with the use of Valtrex
Valtrex Safe-Sex Brochure In Development After Approval For Transmission
GlaxoSmithKline is creating a patient education brochure to be available in October that will emphasize safe-sex practices with the use of Valtrex
Valtrex herpes transmission indication
GlaxoSmithKline's Valtrex (valacyclovir) clears FDA for reduction of the risk of heterosexual transmission of genital herpes when used as a suppressive therapy in combination with safer sex practices. The approval follows the recommendations of the Antiviral Drugs Advisory Committee during a May 14 meeting (1"The Pink Sheet" May 19, 2003, p. 14)...